Bank J Safra Sarasin Buys Into Medtech Expertise

Editorial Staff

3 December 2024

has bought all of medical tech-focused investment house MIV Asset Management AG, Zurich, or “MIV.” The financial terms of the transaction have not been disclosed.

The Switzerland-based bank is targeting the “medtech” sector which it expects to grow amid an ageing population, technological innovation, the rise of chronic diseases, and greater access to healthcare from people in emerging markets.

MIV will maintain its existing investment strategy organisational structure. The CEO of MIV Asset Management is Christoph Gubler.

“This acquisition aligns perfectly with our strategic vision to strengthen our thematic equity offerings and underscores our commitment to providing clients with unparalleled investment opportunities,” Oliver Cartade, head of asset management and institutional clients division, at Bank J Safra Sarasin, said.

At the end of December 2023, Bank J Safra Sarasin managed total client assets of SFr204.3 billion ($343.3 billion), employed approximately 2,500 staff, and had stockholders’ equity of SFr5.8 billion. It sits within the Brazil-headquartered J Safra Group, with total AuM of almost $350 billion, made up of privately-owned banks under the Safra name. The bank has investment holdings in asset-based business sectors such as real estate and agribusiness, and operates in more than 190 locations globally.